225
Views
13
CrossRef citations to date
0
Altmetric
Review

Magnetoliposomes: recent advances in the field of controlled drug delivery

, &
Pages 1323-1334 | Received 31 Jan 2021, Accepted 08 Apr 2021, Published online: 21 Apr 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
  • Anilkumar TS, Shalumon KT, Chen J. Applications of magnetic liposomes in cancer therapies. Curr Parm Des. 2019;25:1490–1504. .
  • Yao Y, Zhou Y, Liu L, et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci. 2020;7:193.
  • Price PM, Mahmoud WE, Al-ghamdi AA, et al. Magnetic drug delivery : where the field is going. Front Chem. 2018;6:619.
  • Tomitaka A, Takemura Y, Huang Z, et al. Magnetoliposomes in controlled-release drug delivery systems. Crit Rev Biomed Eng. 2019;47:495–505.
  • Rajabi M, Mousa SA. Lipid nanoparticles and their application in nanomedicine. Curr Pharm Biotechnol. 2016;17:662–672.
  • Saraf S, Jain A, Jain SK. Advances in liposomal drug delivery to cancer : an overview. J Drug Deliv Sci Technol. 2020;56:101549.
  • Shen S, Huang D, Cao J, et al. Magnetic liposomes for light-sensitive drug delivery and combined photothermal–chemotherapy of tumors. J Mater Chem B. 2019;7:1096–1106.
  • Barreto GR, Kawai C, Tofanello A, et al. Magnetoliposomes as model for signal transmission. R Soc Open Sci. 2019;6:181108.
  • Gogoi M, Kumar N, Patra S. Multifunctional magnetic liposomes for cancer imaging and therapeutic applications. In: Holban A, Grumezescu A, editors. Nanoarchitectonics for smart delivery and drug targeting. Norwich, NY, USA: William Andrew Publishing; 2016. p. 743–782.
  • Soenen S, Hodenius M, Cuyper M. Magnetoliposomes : versatile innovative nanocolloids for use in biotechnology and biomedicine. Nanomedicine. 2009;4:177–191.
  • Kostevšek N. A review on the optimal design of magnetic nanoparticle-Based T2 MRI contrast agents. Magnetochemistry. 2020;6:11.
  • De Cuyper M, Joniau M. Magnetoliposomes. Formation and structural characterization. Eur Biophys J. 1988;15(5):311–319.
  • Sangregorio C, Wiemann JK, Connor CJO, et al. A new method for the synthesis of magnetoliposomes. J Appl Phys. 1999;85:5699.
  • Rio ISR, Rodrigues ARO, Rodrigues CP, et al. Development of novel magnetoliposomes containing nickel ferrite nanoparticles covered with gold for applications in thermotherapy. Materials. 2020;13:815.
  • Rodrigues ARO, Ramos JMF, Gomes IT, et al. Magnetoliposomes based on manganese ferrite nanoparticles as nanocarriers for antitumor drugs. RSC Adv. 2016;6:17302–17313.
  • Cardoso BD, Rio ISR, Rodrigues ARO, et al. Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the model drug curcumin. R Soc Open Sci. 2018;5:181017.
  • Rodrigues ARO, Almeida BG, Rodrigues JM, et al. Magnetoliposomes as carriers for promising antitumor thieno[3,2-b]pyridin-7-arylamines: photophysical and biological studies. RSC Adv. 2017;7:15352–15361.
  • Ghazanfari M, Jaafari M, Shams S, et al. Design and fabrication of multifunctional temperature-sensitive magnetoliposomal nanostructures. Mater Today Commun. 2017;13:102–111.
  • Martina M, Fortin J, Ménager C, et al. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. J Am Chem Soc. 2005;127:10676–10685.
  • Chen Y, Bose A, Bothun G. Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating. ACS Nano. 2010;4:3215–3221.
  • Choi W, Sahu A, Wurm F, et al. Magnetoliposomes with size controllable insertion of magnetic nanoparticles for efficient targeting of cancer cells. RSC Adv. 2019;9:15053–15060.
  • Shaghasemi B, Virk M, Reimhult E. Optimization of magneto-thermally controlled release kinetics by tuning of magnetoliposome composition and structure. Sci Rep. 2017;7:7474.
  • Amstad E, Kohlbrecher J, Müller E. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Lett. 2011;11:1664–1670.
  • Floris A, Ardu A, Musinu A, et al. SPION@liposomes hybrid nanoarchitectures with high density SPION association. Soft Matter. 2011;7:6239–6247.
  • Haša J, Hanuš J, Štěpánek F. Magnetically controlled liposome aggregates for on-demand release of reactive payloads. ACS Appl Mater Interfaces. 2018;10:20306–20314.
  • Salvatore A, Montis C, Berti D, et al. Multifunctional magnetoliposomes for sequential controlled release. ACS Nano. 2016;10:7749–7760.
  • Acharya B, Chikan V. Pulse magnetic fields induced drug release from gold coated magnetic nanoparticle decorated liposomes. Magnetochemistry. 2020;6:52.
  • Zhang S, Niu H, Zhang Y, et al. Biocompatible phosphatidylcholine bilayer coated on magnetic nanoparticles and their application in the extraction of several polycyclic aromatic hydrocarbons from environmental water and milk samples. J Chromatogr A. 2012;1238:38–45.
  • Namdari M, Cheraghi M, Negahdari B, et al. Recent advances in magnetoliposome for heart drug delivery. Artif Cells Nanomed Biotechnol. 2017;45:1–7.
  • Andrade RGD, Veloso SRS, Castanheira EMS. Shape anisotropic iron oxide-based magnetic nanoparticles: synthesis and biomedical applications. Int J Mol Sci. 2020;21:2455.
  • Pereira DSM, Cardoso BD, Rodrigues ARO, et al. Magnetoliposomes containing calcium ferrite nanoparticles for applications in breast cancer therapy. Pharmaceutics. 2019;11:477.
  • Pradhan P, Giri J, Banerjee R, et al. Preparation and characterization of manganese ferrite-based magnetic liposomes for hyperthermia treatment of cancer. J Magn Magn Mater. 2007;311:208–215.
  • Rodrigues ARO, Mendes PMF, Silva PML, et al. Solid and aqueous magnetoliposomes as nanocarriers for a new potential drug active against breast cancer. Colloids Surf B Biointerfaces. 2017;158:460–468.
  • Santos S, Silva N, Espinelli J, et al. Molecular interactions and physico-chemical characterization of quercetin-loaded magnetoliposomes. Chem Phys Lipids. 2019;218:22–33.
  • Mota-Cobián A, Velasco C, Mateo J, et al. Optimization of purification techniques for lumen-loaded magnetoliposomes. Nanotechnology. 2019;31:145102.
  • Hervault A, Thanh NTK. Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale. 2014;6:11553–11573.
  • Hedayatnasab Z, Abnisa F, Daud W. Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application. Mater Des. 2017;123:174–196.
  • Ferreira RV, Martins TMM, Goes AM, et al. Thermosensitive gemcitabine-magnetoliposomes for combined hyperthermia and chemotherapy. Nanotechnology. 2016;27:085105.
  • Ribeiro RFL, Ferreira RV, Davyston C. Cytotoxic effect of thermosensitive magnetoliposomes loaded with gemcitabine and paclitaxel on human primary breast cancer cells (MGSO-3 line). J Nanopart Res. 2020;22:720.
  • Chen B, Zhang R, Wu H, et al. Thermoresponsive magnetoliposome encapsulating doxorubicin and high performance Ferumoxytol for effective tumor synergistic therapy in vitro. J Drug Deliv Sci Technol. 2020;57:101677.
  • Hardiansyah A, Yang MC, Liu TY, et al. Hydrophobic drug-loaded PEGylated magnetic liposomes for drug-controlled release. Nanoscale Res Lett. 2017;12:355.
  • Guo Y, Zhang Y, Ma J, et al. Light/magnetic hyperthermia triggered drug released from multi-functional thermo-sensitive magnetoliposomes for precise cancer synergetic theranostics. J Control Release. 2018;272:145–158.
  • Toro-cordova A, Flores-Cruz M, Santoyo-Salazar J, et al. Liposomes loaded with cisplatin and magnetic nanoparticles: physicochemical characterization, pharmacokinetics, and in-vitro efficacy. Molecules. 2018;23:2272.
  • Spera R, Apollonio F, Liberti M, et al. Controllable release from non-thermal sensitive magnetoliposomes by low-level magnetic stimulation. Colloids Surf B Biointerfaces. 2015;131:136–140.
  • Nappini S, Bombelli F, Bonini M, et al. Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field. Soft Matter. 2010;6:154–162.
  • Joniec A, Sek S, Krysinski P. Magnetoliposomes as potential carriers of doxorubicin to tumours. Chem Eur J. 2016;22:17715–17724.
  • Vlasova KY, Piroyan A, Le-Deygen IM, et al. Magnetic liposome design for drug release systems responsive to super-low frequency alternating current magnetic field (AC MF). J Colloid Interface Sci. 2019;552:689–700.
  • Nardoni M, Valle E, Liberti M, et al. Can pulsed electromagnetic fields trigger on-demand drug release from high-tm magnetoliposomes? Nanomaterials. 2018;8:196.
  • Anilkumar TS, Lu YJ, Chen HA, et al. Dual targeted magnetic photosensitive liposomes for photothermal/photodynamic tumor therapy. J Magn Magn Mater. 2019;473:241–252.
  • Veloso SRS, Martins JA, Hilliou L, et al. Dehydropeptide-based plasmonic magnetogels: a supramolecular composite nanosystem for multimodal cancer therapy. J Mater Chem B. 2020;8:45–64.
  • Yeh Y, Creran B, Rotello VM. Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale. 2012;4:1871–1880.
  • Shen S, Kong F, Guo X, et al. CMCTS stabilized Fe3O4 particles with extremely low toxicity as highly efficient near-infrared photothermal agents for in vivo tumor ablation. Nanoscale. 2013;5:8056–8066.
  • Anilkumar TS, Lu YJ, Chen JP. Optimization of the preparation of magnetic liposomes for the combined use of magnetic hyperthermia and photothermia in dual magneto-photothermal cancer therapy. Int J Mol Sci. 2020;21:1–23.
  • Sharma SK, Shrivastava N, Rossi F, et al. Nanoparticles-based magnetic and photo induced hyperthermia for cancer treatment. Nano Today. 2019;29:100795.
  • Mathiyazhakan M, Wiraja C, Xu C. A concise review of gold nanoparticles-based photo-responsive liposomes for controlled drug delivery. Nano-Micro Lett. 2018;10:10.
  • Rodrigues ARO, Matos JOG, Dias AMN, et al. Development of multifunctional liposomes containing magnetic/plasmonic MnFe2O4/Au core/shell nanoparticles. Pharmaceutics. 2019;11:10.
  • Tomitaka A, Arami H, Huang Z, et al. Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment. Nanoscale. 2018;10:184–194.
  • Song J, Wu B, Zhou Z, et al. Double-layered plasmonic–magnetic vesicles by self-assembly of Janus amphiphilic gold–iron(II,III) oxide nanoparticles. Angew Chem Int Educ. 2017;56:8110–8114.
  • Das R, Rinaldi-Montes N, Alonso J, et al. Boosted hyperthermia therapy by combined AC magnetic and photothermal exposures in Ag/Fe3O4 nanoflowers. ACS Appl Mater Interfaces. 2016;8:25162–25169.
  • Jin Y, Jia C, Huang SW, et al. Multifunctional nanoparticles as coupled contrast agents. Nat Commun. 2010;1:41.
  • Kostevšek N, Cheung CCL, Serša I, et al. Magneto-liposomes as MRI contrast agents: a systematic study of different liposomal formulations. Nanomaterials. 2020;10:889.
  • Skouras A, Papadia K, Mourtas S, et al. Multifunctional doxorubicin-loaded magnetoliposomes with active and magnetic targeting properties. Eur J Pharm Sci. 2018;123:162–172.
  • Garcia-Pinel B, Jabalera Y, Ortiz R, et al. Biomimetic magnetoliposomes as oxaliplatin nanocarriers: in vitro study for potential application in colon cancer. Pharmaceutics. 2020;12(589):1–20. .
  • Estelrich J, Busquets MA, Morán MC. Effect of PEGylation on ligand-targeted magnetoliposomes: a missed goal. ACS Omega. 2017;2:6544–6555.
  • Ribeiro RSG, Belderbos S, Danhier P, et al. Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes. Int J Nanomedicine. 2019;14:5911–5924.
  • Guo H, Chen W, Sun X, et al. Theranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic field. Carbohydr Polym. 2015;118:209–217.
  • Calle D, Negri V, Ballesteros P, et al. Magnetoliposomes loaded with poly-unsaturated fatty acids as novel theranostic anti-inflammatory formulations. Theranostics. 2015;5:489–503.
  • Thébault CJ, Ramniceanu G, Boumati S, et al. Theranostic MRI liposomes for magnetic targeting and ultrasound triggered release of the antivascular CA4P. J Control Release. 2020;322:137–148.
  • Conte C, Ungaro F, Mazzaglia A, et al. Photodynamic therapy for cancer: principles, clinical applications, and nanotechnological approaches. In: Alonso M, Garcia-Fuentes ME, editors. Nano-oncologicals. Advances in delivery science and technology. Cham, Switzerland: Springer; 2014. p. 123–160.
  • Seabra AB. Iron oxide magnetic nanoparticles in photodynamic therapy: a promising approach against tumor cells. In: Rai M, Shegokar R, editors. Metal nanoparticles in pharma. Cham, Switzerland: Springer; 2017. p. 3–20.
  • De Payla LB, Primo FL, Tedesco AC. Nanomedicine associated with photodynamic therapy for glioblastoma treatment. Biophys Ver. 2017;9:761–773.
  • Chen J, Fan T, Xie Z, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials. 2020;237:119827.
  • Hong EJ, Choi DG, Shim MS. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials. Acta Pharm Sin B. 2016;6:297–307.
  • Muehlmann LA, Joanitti GA, Silva JR, et al. Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy. Braz J Med Biol Res. 2011;44:729–737.
  • Silva AKA, Ménager C, Wilhelm C. Magnetic drug carriers: bright insights from light-responsive magnetic liposomes. Nanomedicine. 2015;10:18.
  • Basoglu H, Bilgin MD, Demir MM. Protoporphyrin IX-loaded magnetoliposomes as a potential drug delivery system for photodynamic therapy: fabrication, characterization and in vitro study. Photodiagnosis Photodyn Ther. 2016;13:81–90.
  • Bolfarini GC, Siqueira-Moura MP, Demets GJF, et al. In vitro evaluation of combined hyperthermia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma. J Photochem Photobiol B. 2012;115:1–4.
  • Di Corato R, Béalle G, Kolisnjaj-Tabi J, et al. Combining magnetic hyperthemia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes. ACS Nano. 2015;9:2904–2916.
  • Liu G, Ma J, Li Y, et al. Core-interlayer-shell Fe3O4@mSiO2@lipid-PEG-methotrexate nanoparticle for multimodal imaging and multistage targeted chemo-photodynamic therapy. Int J Pharm. 2017;521:19–32.
  • El-Fakharany EM. Nanoformulation of lactoferrin potentiates its activity and enhances novel biotechnological applications. Int J Biol Macromol. 2020;165:970–984.
  • Shim G, Kim D, Le Q-V, et al. Nonviral delivery systems for cancer gene therapy: strategies and challenges. Curr Gene Ther. 2018;18:3–20.
  • Fernandes F, Kotharkar P, Chakravorty A, et al. Nanocarrier mediated siRNA delivery targeting stem cell differentiation. Curr Stem Cell Res Ther. 2020;15:155–172.
  • Katas H, Hussain Z, Awang SA. Bovine serum albumin-loaded chitosan/dextran nanoparticles: preparation and evaluation of ex vivo colloidal stability in serum. J Nanomater. 2013;2013:536291.
  • Menon JU, Ravikumar P, Pise A, et al. Polymeric nanoparticles for pulmonary protein and DNA delivery. Acta Biomater. 2014;10:2643–2652.
  • Ilarduya CT, Buñuales M, Qian C, et al. Antitumoral activity of transferrin-lipoplexes carrying the IL-12 gene in the treatment of colon cancer. J Drug Target. 2006;14:527–535.
  • Gaber M, Medhat W, Hany M. Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomes. J Control Release. 2017;28:75–91.
  • Shi H, Liu S, Cheng J, et al. Charge-selective delivery of proteins using mesoporous silica nanoparticles fused with lipid bilayers. ACS Appl Mater Interfaces. 2019;11:3645–3653.
  • Moghassemi S, Hadjizadeh A, Omidfar K. Formulation and characterization of bovine serum albumin-loaded niosome. AAPS PharmSciTech. 2017;18:27–33.
  • Zhang P, Steinborn B, Lächelt U, et al. Lipo-oligomer nanoformulations for targeted intracellular protein delivery. Biomacromolecules. 2017;18:2509–2520.
  • Scaletti F, Hardie J, Lee YW, et al. Protein delivery into cells using inorganic nanoparticle–protein supramolecular assemblies. Chem Soc Rev. 2018;47:3421–3432.
  • Marzbali MY, Khosroushahi AY. Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review. Cancer Chemother Pharmacol. 2017;79:637–649.
  • Xu J, Wang H, Xu L, et al. Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy. Biomaterials. 2019;207:1–9.
  • Thomsen LB, Linemann T, Birkelund S, et al. Evaluation of targeted delivery to the brain using magnetic immunoliposomes and magnetic force. Materials. 2019;12:3576.
  • Pan X, Guan J, Yoo J-W, et al. Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery. Int J Pharm. 2008;358:263–270.
  • Yang Y, Xie X, Xu X, et al. Thermal and magnetic dual-responsive liposomes with a cell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy. Colloids Surf B Biointerfaces. 2016;146:607–615.
  • Qiao R, Yang C, Gao M. Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications. J Mater Chem. 2009;19:6274–6293.
  • Thébault CJ, Ramniceanu G, Michel A, et al. In vivo evaluation of magnetic targeting in mice colon tumors with ultra-magnetic liposomes monitored by MRI. Mol Imaging Biol. 2019;21:269–278.
  • Do HD, Ménager C, Michel A, et al. Development of theranostic cationic liposomes designed for image-guided delivery of nucleic acid. Pharmaceutics. 2020;12:854.
  • Wang C, Tao H, Cheng L, et al. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials. 2011;32:6145–6154.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.